Congenital Lymphatic Malformation and Aortic Aneurysm in a Patient with TSC2 Mutation

Abstract

We present a 7-year-old boy with tuberous sclerosis and congenital segmental lymphedema (CSL) of the left leg, as well as two aortic aneurysms. He was treated with everolimus (EVE) since the age of 14 months. His CSL regressed under treatment with EVE. His first aneurysms required operative intervention at age of 17 months. Four months afterward a new aortic aneurysm had been detected above the Dracon graft, but this one remained stable since that time. The patient didn't experience severe side effects. EVE has been well tolerated without disturbance of somatic growth or serious adverse effect.

Keywords

TSC - malformations - lymphedema - aneurysm - aortic aneurysm - everolimus

Statement

The child has been treated at the TSC Center Kork. He was sent to Munich Heart Center for diagnostic procedures and surgery. The Westpfalz Heart Center had been involved in the primary cardiology diagnosis and follow-up treatment.

• References

• 1 Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 2010; 41 (05) 199-208
• 2 Dabora SL, Jozwiak S, Franz DN. , et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68 (01) 64-80
• 3 Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006; 355 (13) 1345-1356
• 4 Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008; 372 (9639): 657-668
• 5 Budde K, Gaedeke J. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition. Am J Kidney Dis 2012; 59 (02) 276-283
• 6 Curatolo P, Jóźwiak S, Nabbout R. ; TSC Consensus Meeting for SEGA and Epilepsy Management. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2012; 16 (06) 582-586
• 7 Krueger DA, Northrup H. ; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49 (04) 255-265
• 8 Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015; 14 (07) 733-745
• 9 Gipson TT, Gerner G, Wilson MA, Blue ME, Johnston MV. Potential for treatment of severe autism in tuberous sclerosis complex. World J Clin Pediatr 2013; 2 (03) 16-25
• 10 Geffrey AL, Shinnick JE, Staley BA, Boronat S, Thiele EA. Lymphedema in tuberous sclerosis complex. Am J Med Genet A 2014; 164A [phone]
• 11 Cottafava F, Cosso D, Brida di Priò S. , et al. [A case of Bourneville's tuberous sclerosis with elephantiasis (caused by lymphedema) of the left leg]. Minerva Pediatr 1986; 38 (1-2): 49-52
• 12 Hirsch RJ, Silverberg NB, Laude T, Weinberg JM. Tuberous sclerosis associated with congenital lymphedema. Pediatr Dermatol 1999; 16 (05) 407-408
• 13 Voudris KA, Skardoutsou A, Vagiakou EA. Tuberous sclerosis and congenital lymphedema. Pediatr Dermatol 2003; 20 (04) 371-373
• 14 Sukulal K, Namboodiri N. Congenital lymphedema: another unique and gender specific stigmata of tuberous sclerosis?. Indian Pediatr 2012; 49 (10) 845
• 15 Prato G, Mancardi MM, Baglietto MG. , et al. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with mammalian target of rapamycin inhibitors. J Child Neurol 2014; 29 (09) NP54-NP57
• 16 Hoshiai S, Oguma E, Sato Y, Konishi T, Minami M. Congenital focal lymphedema as a diagnostic clue to tuberous sclerosis complex: report of two cases diagnosed by ultrasound. Skeletal Radiol 2015; 44 (08) 1165-1168
• 17 Navarre P, Poitras B. Lymphoedema in tuberous sclerosis: case report and review of the literature. J Pediatr Orthop 2014; 34 (06) e27-e32
• 18 Lucas M, Andrade Y. Congenital lymphedema with tuberous sclerosis and clinical Hirschsprung disease. Pediatr Dermatol 2011; 28 (02) 194-195
• 19 Hammill AM, Wentzel M, Gupta A. , et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 2011; 57 (06) 1018-1024
• 20 Wang Y, Zhang X, Liu P, Jiang G, Liu W. Duodenal angiomyolipoma with multiple systemic vascular malformations and aneurysms: a case report and literature review. Oncol Lett 2017; 14 (06) 6659-6663
• 21 Dunet V, Qanadli SD, Lazor R, Beigelman-Aubry C. Multiple pulmonary artery aneurysms in tuberous sclerosis complex. BMJ Case Rep 2013; 2013: bcr2012007911
• 22 Kirkwood ML, Chung J, Timaran CH, Valentine RJ. Extracranial carotid artery aneurysms in two of three monozygotic triplets with tuberous sclerosis complex. J Vasc Surg 2013; 57 (04) 1120-1122
• 23 Patzer L, Basche S, Misselwitz J. Renal artery stenosis and aneurysmatic dilatation of arteria carotis interna in tuberous sclerosis complex. Pediatr Nephrol 2002; 17 (03) 193-196
• 24 Longa L, Scolari F, Brusco A. , et al. A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1997; 12 (09) 1900-1907
• 25 Boronat S, Shaaya EA, Auladell M. , et al. Intracranial arteriopathy tuberous sclerosis complex. J Child Neurol 2013; 29 (07) 912-919
• 26 Lavocat MP, Teyssier G, Allard D, Tronchet M, Freycon F. [Abdominal aortic aneurysm and Bourneville's tuberous sclerosis]. Pediatrie 1992; 47 (7-8): 517-519
• 27 Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 2004; 40 (02) 334-338
• 28 Cao J, Gong L, Guo DC. , et al. Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice. Hum Mol Genet 2010; 19 (10) 1908-1920